Free Trial

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Share Price Crosses Below 50 Day Moving Average - Should You Sell?

Bayer Aktiengesellschaft logo with Medical background

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $6.01 and traded as low as $5.94. Bayer Aktiengesellschaft shares last traded at $6.02, with a volume of 305,657 shares trading hands.

Bayer Aktiengesellschaft Price Performance

The company has a quick ratio of 0.81, a current ratio of 1.32 and a debt-to-equity ratio of 1.19. The company has a 50 day simple moving average of $6.04 and a 200-day simple moving average of $5.84. The stock has a market cap of $24.25 billion, a price-to-earnings ratio of -23.73 and a beta of 0.93.

Bayer Aktiengesellschaft Increases Dividend

The business also recently declared a dividend, which will be paid on Monday, May 12th. Stockholders of record on Wednesday, April 30th will be given a dividend of $0.0224 per share. This represents a dividend yield of 0.38%. This is a boost from Bayer Aktiengesellschaft's previous dividend of $0.02. The ex-dividend date is Tuesday, April 29th. Bayer Aktiengesellschaft's dividend payout ratio is presently -2.78%.

About Bayer Aktiengesellschaft

(Get Free Report)

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.

See Also

Should You Invest $1,000 in Bayer Aktiengesellschaft Right Now?

Before you consider Bayer Aktiengesellschaft, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bayer Aktiengesellschaft wasn't on the list.

While Bayer Aktiengesellschaft currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines